Myron Cohen, MD
Myron Cohen, MD
Director, Institute for Global Health & Infectious Diseases
Associate Vice Chancellor for Global Health & Medical Affairs
Researchers from across UNC’s School of Medicine, Gillings School of Global Public Health and beyond are leading clinical and research responses to the COVID-19 pandemic. Institute faculty members are leading three phase three clinical trials for vaccines and treatments while researchers test early viability of other drug possibilities.
In response to the COVID-19 pandemic, our researchers are studying novel assays, therapeutic vaccines, prophylactic treatment modalities, and treatment options in both the inpatient and outpatient environments. As of August 2020, Institute researchers were conducting 52 COVID-19-related research projects, including testing sites for national phase III clinical trials for potential vaccines.
Africa CDC
Weekly updates on the disease in Africa
Global.health
Open-access global data repository and visualization platform
BBC
A visual guide to the pandemic, regularly updated
Centers for Disease Control
Basic updates and guidance
HIV/AIDS Network Coordination
Resources at intersection of COVID-19 and HIV
Johns Hopkins University Global Case Tracking
A data visualization site with live updates
Journal of the American Medical Association
New England Journal of Medicine
Featured interviews and relevant articles
World Health Organization
Guidance and rolling updates
UNC Gillings School of Global Public Health coronavirus info portal
Recommend another resource
May I Borrow Your COVID Immunity?
Wired talks with Myron Cohen, January 28, 2021
Monoclonal Antibodies Can Prevent COVID-19—But Successful Vaccines Complicate Their Future
Science Magazine talks with Myron Cohen, January 22, 2021
Monoclonal Antibodies to Disrupt Progression of Early Covid-19 Infection
New England Journal of Medicine editorial by Myron Cohen, January 21, 2021
New results from a once-promising therapy show the difficulty of treating COVID-19
Washington Post talks with Jonathan Parr after his JAMA editorial about tocilizumab studies, October 20, 2020
COVID-19 vaccine trials: The only side effect is hope
UNC journalism student Hannah Towey talks with Cindy Gay about her vaccine study, September 29, 2020
Vaccine Watch: Antibody trial seeks bridge to COVID-19 vaccine
ABC News looks at Eli Lilly trial with nursing homes that Myron Cohen is leading, September 3, 2020
An ‘Unprecedented’ Effort to Stop the Coronavirus in Nursing Homes
Myron Cohen talks to New York Times’ Gina Kolata about a clinical trial targeting nursing home residents, August 20, 2020
Coronavirus Treatment and Protection with Monoclonal Antibodies
Myron Cohen talks with JAMA in a video, July 1, 2020
Monoclonal Antibodies for Prevention and Treatment of COVID-19
Myron Cohen, co-author of JAMA viewpoint, June 15, 2020
Combination prevention for COVID-19
Myron Cohen co-writes editorial in Science, May 8, 2020
In a locked-down lab, the UNC coronavirus hunter races for answers
Bloomberg News, March 6, 2020
Looking to the Genome to Track and Treat the New Coronavirus
Ralph Baric, PhD, speaks with NPR’s Science Friday, March 6, 2020
Myron Cohen, MD, discusses coronavirus on CNN, Feb. 7, 2020
Myron Cohen, MD
Director, Institute for Global Health & Infectious Diseases
Associate Vice Chancellor for Global Health & Medical Affairs
Professor of Epidemiology
Professor and Chief, Division of Infectious Diseases
Director, Clinical Core, UNC Center for AIDS Research
Associate Director, General Clinical Research Unit
Adjunct Professor of Epidemiology
Professor of Medicine, Pediatrics, and Epidemiology
Medical Director, UNC Hospitals’ Departments of Hospital Epidemiology (Infection Prevention)
Associate Chief Medical Officer, UNC Health Care